Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral Center
Authors:
- Giovanni MauriGiovanni Mauri
- Francesco Alessandro MistrettaFMFrancesco Alessandro Mistretta
- Guido BonomoGBGuido Bonomo
- Nicola CamisassiNCNicola Camisassi
- Andrea ContiACAndrea Conti
- Paolo Della VignaPVPaolo Della Vigna
- Matteo FerroMFMatteo Ferro
- Stefano LuzzagoSLStefano Luzzago
- Daniele MaiettiniDMDaniele Maiettini
- Gennaro MusiGMGennaro Musi
- Nicolò PiacentiniNPNicolò Piacentini
- Gianluca Maria VaranoGVGianluca Maria Varano
Open Access
Abstract
Image-guided thermal ablations are increasingly applied in the treatment of renal cancers, under the guidance of ultrasound (US) or computed tomography (CT). Sometimes, multiple ablations are needed. The aim of the present study was to evaluate the long-term results in patients with renal mass treated with radiofrequency ablation (RFA) with both US and CT, with a focus on the multiple ablations rate. 149 patients (median age 67 years) underwent RFA from January 2008 to June 2015. Median tumor diameter was 25 mm (IQR 17–32 mm). Median follow-up was 54 months (IQR 44–68). 27 (18.1%) patients received multiple successful ablations, due to incomplete ablation (10 patients), local tumor progression (8 patients), distant tumor progression (4 patients) or multiple tumor foci (5 patients), with a primary and secondary technical efficacy of 100%. Complications occurred in 13 (8.7%) patients (6 grade A, 5 grade C, 2 grade D). 24 patients died during follow-up, all for causes unrelated to renal cancer. In conclusion, thermal ablations with the guidance of US and CT are safe and effective in the treatment of renal tumors in the long-term period, with a low rate of patients requiring multiple treatments over the course of their disease.Keywords
This publication has 36 references indexed in Scilit:
- Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term resultsEuropean Radiology, 2013
- Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell CarcinomaCase Reports in Urology, 2012
- Evidence‐Based Clinical Practice Guideline for Renal Cell Carcinoma: The Japanese Urological Association 2011 updateInternational Journal of Urology, 2012
- Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-upActa Radiologica, 2010
- Navigation Systems for AblationJournal of Vascular and Interventional Radiology, 2010
- Guideline for Management of the Clinical T1 Renal MassJournal of Urology, 2009
- Oncologic Efficacy of CT-Guided Percutaneous Radiofrequency Ablation of Renal Cell CarcinomasAmerican Journal of Roentgenology, 2007
- Radiofrequency Ablation of Renal Cell Carcinoma: Part 2, Lessons Learned with Ablation of 100 TumorsAmerican Journal of Roentgenology, 2005
- Radiofrequency Interstitial Tumor Ablation (RITA) Is a Possible New Modality for Treatment of Renal Cancer: Ex Vivo and in Vivo ExperienceJournal of Endourology, 1997
- Tissue ablation with radiofrequency: Effect of probe size, gauge, duration, and temperature on lesion volumeAcademic Radiology, 1995